News Briefs

Hemab scores $55m Series A

Hemab, a developer of therapeutics for serious underserved bleeding and thrombosis disorders, has raised $55 million in Series A financing.

-

Hemab, a developer of therapeutics for serious underserved bleeding and thrombosis disorders, has raised $55 million in Series A financing. Novo Holdings, HealthCap and RA Capital Management led the round.

Source: Press Release